Table 2.
Comparison of laboratory value of patients between the metformin group and no-metformin group
| Laboratory parameter | Metformin group (n = 104) | No-metformin group (n = 179) | P-value |
|---|---|---|---|
| White blood count (×109/L) | 6.12 (5.12–7.20) | 6.11 (5.02–7.98) | 0.55 |
| Lymphocyte count (×109/L) | 1.24 (0.87–1.77) | 1.08 (0.69–1.55) | 0.13 |
| Monocyte count (×109/L) | 0.50 (0.41–0.63) | 0.50 (0.36–0.64) | 0.55 |
| Neutrophil count (×109/L) | 4.18 (3.29–5.19) | 4.24 (3.09–5.87) | 0.50 |
| Eosinophil count (×109/L) | 0.05 (0.01–0.11) | 0.04 (0.00–0.09) | 0.31 |
| Basophil count (×109/L) | 0.01 (0.01–0.03) | 0.01 (0.01–0.02) | 0.86 |
| Platelet count (×109/L) | 237 (177–314) | 222 (160–274) | 0.06 |
| Alanine aminotransferase levels (U/L) | 23.0 (14.5–32.5) | 22.0 (15.0–33.5) | 0.67 |
| Aspartate aminotransferase levels (U/L) | 23.5 (18.0–33.0) | 25.0 (19.0–35.5) | 0.39 |
| Gamma-glutamyltransferase levels (U/L) | 30.0 (20.0–46.3) | 28.0 (19.0–50.0) | 0.91 |
| Serum creatinine levels (umol/L) | 69.0 (57.0–85.0) | 71.0 (56.0–90.0) | 0.36 |
| Blood urea levels (mmol/L) | 4.95 (4.00–6.00) | 5.10 (3.65–7.20) | 0.38 |
| C-reactive protein levels (mg/L) | 20.7 (3.40–68.2) | 20.9 (2.62–83.6) | 0.78 |
| Fasting blood glucose levels (mmol/L) | 9.19 (6.83–14.8) | 7.36 (6.10–11.8) | < 0.01 |
Data are expressed as median (IQR). P-values denoted the comparison between the metformin group and no-metformin group.